BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2219991)

  • 1. [The lymphocyte transformation test in sarcoidosis].
    Heidenbluth I; Richter G; Leucht V
    Z Erkr Atmungsorgane; 1990; 175(1):3-8. PubMed ID: 2219991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of different combinations of immunological signs for differential diagnosis of lung diseases].
    Knoring BE; Saburenkova EP; Feigin MI
    Probl Tuberk; 1991; (7):53-6. PubMed ID: 1754592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The response of alveolar lymphocytes induced by Propionibacterium acnes in pulmonary sarcoidosis: correlation with clinical studies, pulmonary function studies and bronchoalveolar lavage].
    Nakata Y; Kataoka M; Ejiri T; Mori Y; Hioka T; Maeda T; Hosoya S; Ohnoshi T; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jul; 27(7):837-41. PubMed ID: 2810973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The "sarcoidosis-lymphoma syndrome"--a lymphocyte dysregulation?].
    Linnenberg HS; Medici TC; Rhyner K
    Pneumologie; 1992 Jun; 46(6):229-35. PubMed ID: 1495911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The serum level of the secreted interleukin 2 receptor (sIL-2R): a lymphocyte activity parameter in sarcoidosis].
    Müller-Quernheim J; Strausz J; Ferlinz R
    Pneumologie; 1990 Feb; 44 Suppl 1():213-4. PubMed ID: 2367367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary sarcoidosis. Presumptions, facts].
    Böttger D
    Z Erkr Atmungsorgane Folia Bronchol; 1973-1974; 139(1):25-92. PubMed ID: 4605898
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic value of the lymphocyte toxicity of the serum and its correlations with immunoglobulins in lymphnodal-pulmonary sarcoidosis].
    Brun J; Biot N; Kofman J; Perrin-Fayolle M
    Lyon Med; 1971 May; 225(10):937-44. PubMed ID: 4105928
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the responsiveness of alveolar T cells to proliferative stimuli and on surface antigens].
    Yamaguchi E
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):224-36. PubMed ID: 8509065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of serum on lymphocyte transformation by phytohemagglutinin in patients with intrathoracic sarcoidosis.
    Terasawa M
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):69-85. PubMed ID: 6205448
    [No Abstract]   [Full Text] [Related]  

  • 10. [T-lymphocyte subpopulations in sarcoidosis].
    Gergert VIa; Miuller Sh; Kolodiazhnaia NS
    Probl Tuberk; 1984 Sep; (9):65-9. PubMed ID: 6334302
    [No Abstract]   [Full Text] [Related]  

  • 11. Sarcoidosis is not associated with a generalized defect in T cell suppressor function.
    Saltini C; Spurzem JR; Kirby MR; Crystal RG
    J Immunol; 1988 Mar; 140(6):1854-60. PubMed ID: 2964485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The evidence capacity of the lymphocyte-transformation-test and the quantitative immunoglobulin-determination in sarcoidosis (author's transl)].
    Zochert J; Thomas U; Bösel B
    Z Erkr Atmungsorgane; 1977 Aug; 149(2):243-6. PubMed ID: 416607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T4/T8 ratio in bronchoalveolar lavage in sarcoidosis--a marker of activity and/or prognosis?].
    de Wall N; Atay Z; Endres P
    Pneumologie; 1993 Feb; 47(2):53-9. PubMed ID: 8464852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response.
    Hudspith BN; Brostoff J; McNicol MW; Johnson NM
    Clin Exp Immunol; 1984 Aug; 57(2):324-30. PubMed ID: 6331921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical aspects of sarcoidosis. With special reference to angiotensin-converting enzyme (ACE).
    Rømer FK
    Acta Med Scand Suppl; 1984; 690():3-96. PubMed ID: 6097101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the serum of patients with an active form of pulmonary sarcoidosis on the biological activity of lymphocytes and leukocytes of healthy persons].
    Wolska-Goszka L
    Pol Tyg Lek; 1984 Feb; 39(7):209-13. PubMed ID: 6379620
    [No Abstract]   [Full Text] [Related]  

  • 17. T gamma cells in sarcoidosis: E rosetting monocytes suppress lymphocyte transformation.
    Johnson NM; Brostoff J; Hudspith BN; Boot JR; McNicol MW
    Clin Exp Immunol; 1981 Mar; 43(3):491-6. PubMed ID: 6974625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic reactivity of the body in sarcoidosis patients].
    Chernushenko EF; Goncharova SI; Kogosova LS
    Klin Med (Mosk); 1983 Dec; 61(12):44-9. PubMed ID: 6608033
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mediastino-pulmonary sarcoidosis].
    Delaval P; Desrues B; Quinquenel ML; Lineau C; Lena H
    Rev Pneumol Clin; 1993; 49(6):310-6. PubMed ID: 8066367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blast lymphocyte transformation (LTT), rosette (E-RFC) and leukocyte migration inhibition (MIF) tests in persons exposed to the action of lead during work. Report II.
    Jaremin B
    Bull Inst Marit Trop Med Gdynia; 1983; 34(3-4):189-97. PubMed ID: 6399005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.